BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Report

AUXILIUM PHARMACEUTICALS

via HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)

4th Quarter (Oct 1 - Dec 31) · 2013Posted Jan 22, 2014Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: AUXILIUM PHARMACEUTICALS
Description: Drug Manufacturer
Location: Pennsylvania · United States of America

Registrant

Firm: HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Description: Law Firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Compounding pharmacy legislation
Lobbyistsmr CHARLES M. CLAPTON
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

AUXILIUM PHARMACEUTICALS — Lobbying — Receipts Report